Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
R3 Medical is a global leader in regenerative medicine, specializing in the delivery of stem cell and exosome therapies alongside comprehensive medical training for practitioners. The company operates a vast network of clinics under the R3 Stem Cell brand and provides CME-accredited courses through R3 Medical Training, focusing on biologics such as umbilical cord-derived mesenchymal stem cells and platelet-rich plasma. R3 Medical's business model integrates clinical treatment protocols, provider education, and the distribution of regenerative products to address chronic pain, orthopedic conditions, and systemic diseases. With a presence in multiple countries, the organization aims to make advanced regenerative treatments accessible and standardized for both patients and healthcare providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on R3 Medical.